Using strategic price negotiations to contain costs and expand access to medicines in China
Saved in:
| Main Author: | Lizheng Xu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-01-01
|
| Series: | BMJ Global Health |
| Online Access: | https://gh.bmj.com/content/5/1/e002256.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impacts of National Reimbursement Drug Price Negotiation on drug accessibility, utilization, and cost in China: a systematic review
by: Zheng Zhu, et al.
Published: (2025-02-01) -
Reimbursement prices of new, innovative medicines in Germany: a comparison of negotiation and cost-effectiveness analysis
by: Afschin Gandjour -
Impact of the National Drug Price Negotiation policy on the price, usage, and affordability of anticancer medicines in Shandong Province, China
by: Yaqun Sun, et al.
Published: (2025-01-01) -
THE STRATEGIC ROLE OF COMMUNICATION AND NEGOTIATION
by: Geovana-Albertina ZOICAN
Published: (2025-07-01) -
Cardiovascular medicine prices as an indicator of access to medicines and their rational use
by: C M. Razzakova, et al.
Published: (2019-05-01)